Status:

COMPLETED

Management of Infants Born to Group B Streptococcus Positive Mothers.

Lead Sponsor:

IRCCS Burlo Garofolo

Collaborating Sponsors:

Friuli Venezia Giulia Regional Health Authority

Conditions:

Group B Streptococcus

Sepsis

Eligibility:

All Genders

Brief Summary

Intrapartum antibiotic prophylaxis has greatly decreased but not abolished early-onset neonatal sepsis caused by GBS. According to current recommendations, the evaluation of infants at risk for GBS se...

Detailed Description

After implementation of appropriate guidelines, early-onset GBS sepsis has become a low incidence disease (CDC). Recent rates are as low as 0.34 cases /1000 live births. According to CDC recommendatio...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • All newborns born in Friuli Venezia Giulia Region (Italy)

Exclusion

    Key Trial Info

    Start Date :

    July 1 2004

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    December 1 2006

    Estimated Enrollment :

    16394 Patients enrolled

    Trial Details

    Trial ID

    NCT00716781

    Start Date

    July 1 2004

    End Date

    December 1 2006

    Last Update

    July 16 2008

    Active Locations (0)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 0 (0 locations)

    No Results Found

    We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

    Management of Infants Born to Group B Streptococcus Positive Mothers. | DecenTrialz